We are international
Donate
•health professionals   TEXT SIZE   
    back

ASH 2007 WEBCAST

We are pleased to present these overviews of the 49th Annual American Society of Hematology Meeting (ASH) that was held in Atlanta, Georgia from December 8-11, 2007.

ASH 2007
    next      view all

ASH Overview
Elijah Alexander: ASH 2007: A Patient's Perspective
Elijah Alexander
Former NFL lineman and Myeloma Patient shares his reactions on attending ASH for the first time

Dr. Kyle: An Overview of the 49th Annual American Society of Hematology Meeting (ASH) 2007
Dr. Robert Kyle
Mayo Clinic
Rochester, Minnesota
Chair, IMF Scientific Advisory Board

Dr. Durie: An Overview of the 49th Annual American Society of Hematology Meeting (ASH) 2007
Dr.Brian G.M. Durie
Cedars Sinai Cancer Center
Los Angeles, California
Chair of the International Myeloma Foundation

Dr. San Miguel: A Review of Novel Agents Presented at the 49th Annual American Society of Hematology Meeting (ASH) 2007
Dr. Jesús San Miguel
Hospital Clinico Universitario
Universidad de Salamanca
Salamanca, Spain
Member, IMF Board of Scientific Advisors

Dr. Gertz - An Overview of the 49th Annual American Society of Hematology Meeting (ASH) 2007
Morie A Gertz, MD
Mayo Clinic
Rochester, Minnesota
Member, IMF Board of Scientific Advisors

Dr. Jagannath: ASH 2007: New Drug Combinations as Induction Therapy
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center
New York, NY
Member, IMF Board of Scientific Advisors

Dr. Boccadoro - An Overview of the 49th Annual American Society of Hematology Meeting (ASH) 2007
Mario Boccadoro, MD
Divisione Universitaria di Ematologia
Ospedale Molinette
Torino, Italy
Member, IMF Board of Scientific Advisors

ASH 2007 INTERNATIONAL WEBCASTS
We are pleased to be able to present overviews of ASH 2007 in French, Spanish, German, Italian, Turkish, and Czech.

Newly Diagnosed Myeloma
Dr. San Miguel - A Phase 3 Study Comparing BortezomibMelphalanPrednisone (VMP) with MelphalanPrednisone (MP) in Newly Diagnosed Multiple Myeloma.
Dr. Jesús San Miguel
Hospital Clinico Universitario
Universidad de Salamanca
Salamanca, Spain
Member, IMF Board of Scientific Advisors

Dr. Rajkumar - A Randomized Trial of Lenalidomide Plus High-Dose Dexamethasone (RD) Versus Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group
S. Vincent Rajkumar, MD
Mayo Clinic
Rochester, Minnesota
Member, IMF Board of Scientific Advisors

    next      view all